The Antwerp University Hospital (UZA)
Welcome,         Profile    Billing    Logout  
 0 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vandamme, Timon
SAUNA, NCT05701241: Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients

Recruiting
4
270
Europe
Somatostatin analog, lanreotide, octreotide, sandostatin, somatuline
University Hospital, Antwerp, Erasmus Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Belgium Health Care Knowledge Centre
Gastroenteropancreatic Neuroendocrine Tumor
04/29
04/34
BALLAD, NCT04257461: A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma

Active, not recruiting
3
30
Europe
Fluoropyrimidine, Capecitabine, LV5FU2, Oxaliplatin, Xeloda
Belgian Group of Digestive Oncology, Kom Op Tegen Kanker, Cancer Research UK
Small Bowel Adenocarcinoma
12/25
12/25
SAFIR-ABC10, NCT05615818: Personalized Medicine for Advanced Biliary Cancer Patients

Recruiting
3
800
Europe
Futibatinib, Ivosidenib, Tibsovo, Zanidatamab, Trastuzumab, Zercepac, Neratinib, Nerlynx, Encorafenib, Braftovi, Binimetinib, Mektovi, Niraparib, Zejula, Cisplatin, Gemcitabine
UNICANCER, Cancer Research UK & UCL Cancer Trials Centre, Belgian Group of Digestive Oncology, National Cancer Institute, France, Cancer Research UK, Taiho Oncology, Inc., Servier, Zymeworks BC Inc., Accord Healthcare, Inc., Pierre Fabre Medicament
Biliary Tract Neoplasms
06/27
06/28
Actuate 1801, NCT03678883 / 2018-003739-32: 9-ING-41 in Patients with Advanced Cancers

Active, not recruiting
2
350
Europe, Canada, US
9-ING-41, Gemcitabine - 21 day cycle, Gemzar, Doxorubicin., Doxil, Adriamycin, Lomustine, CCNU, Gleostine, Carboplatin., Paraplatin, Nab paclitaxel., Abraxane, Protein-bound paclitaxel, Nanoparticle albumin-bound paclitaxel, Paclitaxel., Taxol, Gemcitabine - 28 day cycle, Irinotecan, Camptosar
Actuate Therapeutics Inc., Actuate Therapeutics Inc
Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer, Refractory Cancer, Refractory Neoplasm, Refractory Non-Hodgkin Lymphoma, Pancreatic Adenocarcinoma, Resistant Cancer, Neoplasm Metastasis, Neoplasm of Bone, Neoplasm, Breast, Neoplasm of Lung, Neoplasms,Colorectal, Neoplasms Pancreatic, Malignant Glioma, Malignancies, Malignancies Multiple, Bone Metastases, Bone Neoplasm, Bone Cancer, Pancreas Cancer, Pancreatic Neoplasms, Breast Neoplasms, Acute T Cell Leukemia Lymphoma
01/25
01/26
NALPAC, NCT05472259 / 2020-003889-39: A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC

Recruiting
2
134
Europe
Nanoliposomal irinotecan, Onyvide, 5 FU, Fluorouracil, Leucovorin, Folinate, Elvorine, Oxaliplatin
Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels
Metastatic Pancreatic Ductal Adenocarcinoma
12/26
12/27
STEREOPAC, NCT05083247: Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Recruiting
2
256
Europe
mFOLFIRINOX or Gemcitabine nab-paclitaxel, mFFX or Gem/Nab-p, Isotoxic High-Dose (iHD)-SBRT, Surgery
Erasme University Hospital, Jules Bordet Institute, Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels
Pancreatic Neoplasm, Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma
12/27
12/30
IL15-TransDC, NCT05964361: First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients

Recruiting
1/2
10
Europe
IL15-transpresenting WT1-targeted Dendritic Cell Vaccine, IL15/IL15Ra/WT1 DC vaccine, IL15-transpresenting WT1-targeting DC vaccine
University Hospital, Antwerp, Kom Op Tegen Kanker, Stichting tegen Kanker
Esophageal Cancer, Pancreas Cancer, Ovarian Cancer, Liver Cancer
04/25
09/25
BE-FORCE, NCT06541080: Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the Consortium

Recruiting
N/A
550
Europe
Shallow Whole Genome Sequencing (sWGS)-GIPXplore, methylation-sensitive restriction enzymes (MSRE)-Single-molecule molecular inversion probes (smMIP)-seq assay
University Hospital, Antwerp, Universitaire Ziekenhuizen KU Leuven, Universiteit Antwerpen, KU Leuven
Neuroendocrine Neoplasms
12/28
12/30
TORPEDO, NCT06691425: Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma

Recruiting
N/A
160
Europe
Stereotactic Body Radiation Therapy (SBRT), Chemotherapy
Cancer Research Antwerp, Kom Op Tegen Kanker, Naslund Medical AB, Varian Medical Systems
Non-metastasized Unresectable Pancreatic Carcinoma
07/30
07/30
eCAN, NCT06007001: Telerehabilitation and Tele-psychological Support in Cancer Patients JA

Recruiting
N/A
354
Europe, RoW
Telemedicine
Sciensano, European Commission
Cancer
09/24
09/24
NCT05268952: A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Recruiting
N/A
100
Europe, RoW
Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
University Hospital, Antwerp, Universiteit Antwerpen
Neuroendocrine Tumors
05/25
12/25
NCT05704530: Liquid Biopsies in Esophageal Cancer

Recruiting
N/A
248
Europe
Blood sample
Universitaire Ziekenhuizen KU Leuven, Kom Op Tegen Kanker
Esophageal Cancer
09/25
12/26
COPERNIC, NCT05487248: A Study of On-treatment CtDNA Changes in Chemo-refractory Colorectal Cancer Patients

Recruiting
N/A
103
Europe
Blood Sample Collection
Jules Bordet Institute, Hoffmann-La Roche
Unresectable Locally Advanced Colorectal Cancer, Metastatic Colorectal Cancer, Candidate for Third-line or Subsequent Lines of Therapy
04/26
12/26
SHAPERS, NCT06052332: Efficacy and Safety of SCRT Versus TNT in Older Patients With Locally Advanced Rectal Cancer

Recruiting
N/A
230
Europe
Short course radiotherapy, Adjuvant chemotherapy (optional), Total mesorectal excision, Total neoadjuvant therapy
Jules Bordet Institute
Locally Advanced Rectal Cancer, Older People
12/29
12/33
Quali-NET, NCT05268783: Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk

Recruiting
N/A
1000
Europe
EORTC QLQ-C30, EORTC QLQ-GI.NET21, Satisfaction survey
University Hospital, Antwerp
Quality of Life
12/29
12/29

Download Options